Mohammed A. Aleskandarany
Rho-GTPase activating protein 18: a biomarker associated with good prognosis in invasive breast cancer
Aleskandarany, Mohammed A.; Sonbul, Sultan N.; Surridge, Rachel; Mukherjee, Abhik; Caldas, Carlos; Diez-Rodriguez, Maria; Ashankyty, Ibraheem; Albrahim, Khalil I.; Elmouna, Ahmed M.; Aneja, Ritu; Martin, Stewart G.; Ellis, Ian O.; Green, Andrew R.; Rakha, Emad A.
Authors
Sultan N. Sonbul
Rachel Surridge
Dr ABHIK MUKHERJEE ABHIK.MUKHERJEE1@NOTTINGHAM.AC.UK
Clinical Associate Professor
Carlos Caldas
Maria Diez-Rodriguez
Ibraheem Ashankyty
Khalil I. Albrahim
Ahmed M. Elmouna
Ritu Aneja
Stewart G. Martin
Ian O. Ellis
ANDREW GREEN ANDREW.GREEN@NOTTINGHAM.AC.UK
Associate Professor
Emad A. Rakha
Abstract
Background: The prognostic value of lymphovascular invasion (LVI) in breast cancer (BC) has been demonstrated in several independent studies. However, identification of driver molecules for LVI remains a challenging task. Large-scale transcriptomic profiling of histologically validated LVI can potentially identify genes that regulate LVI.
Methods:Integrative bio-informatics analyses of the METABRIC study were performed utilising a subset of strictly defined LVI using histological and immunohistochemical (IHC) criteria. ARHGAP18 was amongst the top differentially expressed genes between LVI+ and LVI- BC with a 1.8 fold change. The prognostic impact of ARHGAP18 gene expression was assessed in the METABRIC dataset (n=1980) and externally validated using the online BC gene expression datasets utilising bc-GenExMiner v4.0 (n=2016). Subsequently, ARHGAP18 protein expression was assessed on a large cohort of invasive BC (n=959) with long term follow-up using IHC.
Results: Pooled analysis of ARHGAP18 mRNA expression showed that overexpression was associated with better outcome (p<0.001, Hazard ratio (HR) =0.82, 95%CI 0.75-0.90). ARHGAP18 protein was expressed in the cytoplasm and nuclei of the tumour cells and its expression was positively associated with good prognostic variables. Lack of cytoplasmic expression showed associations with LVI (p=0.006), epithelialmesenchymal transition and the HER+ subtype (p=0.01). Loss of nuclear expression was associated higher grade, HER2+ and high Ki67LI (p=0.001). Cytoplasmic and nuclear expression showed a positive association with improved survival independent of other variables (P =0.01, HR = 0.74, 95%CI 0.60-87).
Conclusions: ARHGAP18 expression at transcriptomic and protein levels is associated with improved patients’ outcomes whose deregulation may play a role in tumour progression and the development of LVI in BC. Further assessment of its potential therapeutic value in BC is warranted.
Citation
Aleskandarany, M. A., Sonbul, S. N., Surridge, R., Mukherjee, A., Caldas, C., Diez-Rodriguez, M., Ashankyty, I., Albrahim, K. I., Elmouna, A. M., Aneja, R., Martin, S. G., Ellis, I. O., Green, A. R., & Rakha, E. A. (2017). Rho-GTPase activating protein 18: a biomarker associated with good prognosis in invasive breast cancer. British Journal of Cancer, 117(8), 1176-1184. https://doi.org/10.1038/bjc.2017.261
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 14, 2017 |
Online Publication Date | Aug 22, 2017 |
Publication Date | Aug 22, 2017 |
Deposit Date | Jul 20, 2017 |
Publicly Available Date | Aug 22, 2017 |
Journal | British Journal of Cancer |
Print ISSN | 0007-0920 |
Electronic ISSN | 1532-1827 |
Publisher | Cancer Research UK |
Peer Reviewed | Peer Reviewed |
Volume | 117 |
Issue | 8 |
Pages | 1176-1184 |
DOI | https://doi.org/10.1038/bjc.2017.261 |
Keywords | ARHGAP18, Lymphovascular invasion, Immunohistochemistry, Breast cancer, Prognosis |
Public URL | https://nottingham-repository.worktribe.com/output/878336 |
Publisher URL | http://www.nature.com/bjc/journal/vaop/ncurrent/full/bjc2017261a.html?foxtrotcallback=true |
Contract Date | Jul 20, 2017 |
Files
ARHGAP18 Manuscript_Aleskandarany et al_SUBMITTED 12 07 17.pdf
(898 Kb)
PDF
You might also like
Nostrin as a marker related to low grade and better prognosis in breast cancer
(2016)
Presentation / Conference Contribution
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search